Concepedia

M. Kluibenschaedl

MK

2

Publications

45

Citations

2

H-Index

2014

Active since

Affiliations

University of Utah Hospital(Current)

Harvard University

Massachusetts General Hospital

University of Utah

Fred Hutch Cancer Center

M. Kluibenschaedl is an author at University of Utah Hospital specializing in drug discovery, cancer research, and health policy.

Top concepts

MedicineOncologyPharmacologyHealth PolicyDrug DiscoveryCancer ResearchClinical TrialsPharmacotherapyOutcomes ResearchCost-effectiveness Analysis

Publications per year

2014–2015

2

Publications

2

Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis

Ursula Rochau, M. Kluibenschaedl, David D. Stenehjem et al. · Leukemia Research and Treatment · 2015 · 24 citations · Full text

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

Ursula Rochau, Gaby Sroczynski, Dominik Wolf‎ et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 21 citations

Cost-effectiveness Analysis, Mixed-phenotype Acute Leukemia, Pharmacotherapy +17

Rows per page

1–2 of 2